Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 294 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 11/30/16
Due: 11/30/17
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison
Phase: N/A
Priority: Normal
Start: 12/26/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 08/21/17
End: 06/01/18
Due: 06/01/19
Phase: N/A
Priority: Normal
Start: 12/07/16
End: 11/29/17
Due: 11/29/18
Phase: N/A
Priority: Normal
Start: 02/20/13
End: 08/31/32
Due: 08/31/33
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 03/18/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 03/17/21
End: 07/08/21
Due: 07/08/22
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 09/28/17
End: 05/25/22
Due: 05/25/23
Phase: N/A
Priority: Normal
Start: 08/31/99
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 10/29/20
End: 12/09/22
Due: 12/09/23
Phase: N/A
Priority: Normal
Start: 11/06/20
End: 08/24/22
Due: 08/24/23
Phase: N/A
Priority: Normal
Start: 09/03/19
End: 04/03/20
Due: 04/03/21
Phase: N/A
Priority: Normal
Start: 02/26/18
End: 07/02/18
Due: 07/02/19
Phase: N/A
Priority: Normal
Start: 10/20/03
End: 10/31/50
Due: 10/31/51
Phase: N/A
Priority: Normal
Start: 03/11/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 06/08/19
End: 02/10/20
Due: 02/10/21
Phase: N/A
Priority: Normal
Start: 06/30/21
End: 12/30/22
Due: 12/30/23
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 05/31/98
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 10/01/16
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 12/31/14
End: -
Due: -